Hearing Loss & Your Brain
Hearing loss can affect one in three people over the age of 65, and recent studies have pointed to a link between cognitive decline, which leads to dementia and hearing loss. Hearing loss is incredibly common and is strongly associated with aging, although it can occur for several reasons. About 25 percent of people aged 65 to 74 years, and 50% of those aged 75 years and older suffer from hearing loss. And yet in this age group, fewer than 1 in 3 people who may benefit from hearing aids have ever used them.
Untreated Hearing Loss Can Affect Cognitive Abilities
Scientific studies indicate that hearing plays a critical role in brain health – and hearing loss can lead to diminished cognitive function. Fortunately, there's a chance that more aggressively treating hearing loss may delay cognitive decline and dementia.
Cognivue Thrive®: Test Your Cognitive Function
Manhattan Audiology incorporates cognitive screening as part of a comprehensive audiological evaluation to fully understand our patients’ functional and communication needs. This assists in our hearing treatment plans and assesses outcomes.
This patient service has been introduced after considering recent research on the correlation between hearing loss and mild cognitive impairment (MCI). Specifically, the 2020 Report of the Lancet Commission: Dementia prevention, intervention, and care.
We also put considerable weight behind the research findings from Johns Hopkins, which has determined those with untreated hearing loss had a 55% greater risk of developing dementia compared to those with normal hearing.
During the screening, we test central function, which includes cognitive processes important for understanding speech. This is necessary for providing a more comprehensive treatment plan for age-related hearing loss. We use a screening device called Cognivue Thrive®, which is based upon Cognivue’s FDA-cleared technology.
Cognivue Thrive® has proven to be highly sensitive, reliable, and very much suited for detecting mild cognitive impairment but is not a stand-alone diagnostic tool.